Warby Parker Inc. (WRBY)

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Ticker
WRBY
Exchange
NYSE
Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$3.17B
52-week range
$14.96 - $31.00

Valuation

Share price
$25.48 (close of Nov 6, 2026)
P/E (TTM)
509.60x
Price to book
7.85x
Price to free cash flow
148.80x
Enterprise value
$3.14B
Book value per share
$3.24

Price performance

PeriodChange
1 day-2.30%
5 days+3.54%
1 month-2.86%
3 months-5.49%
6 months+15.66%
Year to date+16.93%
1 year+50.50%
3 years+84.24%
5 years-55.57%
All time-53.24%

Short interest

As of
Oct 15, 2026
Short % of float
23.58%
Shares short
20.50M
Days to cover
7.16
Change since prior report
+12.68%
Source
FINRA consolidated short interest

Profitability and growth

Return on equity
0.45%
Return on invested capital
-0.89%
Return on assets
0.23%
Return on capital employed
-0.93%
Gross margin
53.97%
Net margin
0.19%
EBITDA margin
5.15%
Revenue growth
13.04%
Free cash flow growth
26.00%

Cash flow and balance sheet

Free cash flow yield (TTM)
0.67%
Current ratio
2.26x
Net debt to EBITDA
-0.41x

Latest reported year

Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$871.90M
Cost of revenue
$401.33M
Gross profit
$470.58M
EBITDA
$44.94M
Net income
$1.64M
Earnings per share
$0.01
Shares outstanding
122.67M

Income statement by year

Period endRevenueGross profitNet incomeEPS
2025-12-31$871.90M$470.58M$1.64M$0.01
2024-12-31$771.32M$426.83M-$20.39M-$0.17
2023-12-31$669.76M$365.22M-$63.20M-$0.54
2022-12-31$598.11M$341.06M-$110.39M-$0.96
2021-12-31$540.80M$317.75M-$144.27M-$2.21
2020-12-31$393.72M$231.94M-$55.92M-$1.05
2019-12-31$370.46M$223.11M--$1.10

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2025-12-3153.97%0.19%0.45%-0.89%
2024-12-3155.34%-2.64%-6.00%-5.33%
2023-12-3154.53%-9.44%-20.94%-15.12%
2022-12-3157.02%-18.46%-38.51%-24.17%
2021-12-3158.76%-26.68%-50.44%-50.23%
2020-12-3158.91%-14.20%--
2019-12-3160.22%0.00%--

Cash and debt by year

Period endCash
2025-12-31$286.36M
2024-12-31$254.16M
2023-12-31$216.89M
2022-12-31$208.59M
2021-12-31$256.42M
2020-12-31$314.08M

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-12-31$43.74M$34.54M
2024-12-31$34.71M$47.29M
2023-12-31$7.32M$70.51M
2022-12-31-$49.81M$98.03M
2021-12-31-$80.51M$107.15M
2020-12-31$12.69M$44.91M
2019-12-31-$11.24M$8.50M

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-11-05Sep 2026$0.03
2026-08-06Jun 2026$0.05
2026-05-07Mar 2026$0.04
2026-02-26Dec 2025$0.01
2025-11-06Sep 2025$0.04
2025-08-07Jun 2025$0.02
2025-05-08Mar 2025$0.07
2025-02-27Dec 2024-$0.03

Filings and sources

Company website
warbyparker.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Intuitive Surgical Inc (ISRG) · Becton Dickinson & Co (BDX) · Medline Inc. (MDLN) · ResMed Inc (RMD) · Alcon Inc (ALC) · West Pharmaceutical Services Inc (WST) · Solventum Corp (SOLV) · Baxter International Inc (BAX)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades